BioSpace News Archive

NeoChord, Inc., a privately-held medical technology company, is leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation with more than a decade of commercial experience in treating over 1,800 patients globally with the transapical technology.

Umoja Biopharma, Inc., an immuno-oncology company pioneering off-the-shelf, integrated therapeutics that reprogram immune cells in vivo to treat patients with solid and hematologic malignancies, announced today that it will have three poster presentations at the 2022 Society for Immunotherapy for Cancer 37th Annual Meeting.

Certara, Inc., (Nasdaq: CERT) a global leader in biosimulation, today announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has renewed its licenses of Certara’s Simcyp™ Simulator, Phoenix™ biosimulation software, and Pinnacle 21™ Enterprise software.

Alafair Biosciences, Inc., a commercial-stage medical device company, announced today that it has been selected as one of Austin Business Journal’s 2022 Best Places to Work.

Blueprint Medicines Corporation today announced that it will host an Investor Day for analysts and investors on Tuesday, November 1, 2022 beginning at 8:30 a.m. ET in New York City.

Shionogi Presents Real-World Evidence Showing Strong Efficacy with Fetroja ® (cefiderocol) Against Treatment Resistant Bacterial Infections at IDWeek 2022.

Lygos, Inc. , a vertically integrated provider of safe and sustainable specialty ingredients, today announced that Chief Executive Officer Eric Steen , PhD, will present at the upcoming Advanced Bioeconomy Leadership Conference (ABLC) Next 2022, which is being held from October 26-28, 2022 in San Francisco.

Anji Pharmaceuticals and Population Health Partners today announced that they have entered into a strategic collaboration, bringing together two complementary teams to jointly address high prevalence human diseases.

Moderna, Inc. today announced new clinical data on its bivalent Omicron-containing booster, mRNA-1273.214.

Avinger, Inc. today announced that Chief Executive Officer Jeff Soinski will participate in the following investor conference event during October 2022.